NovaBay Pharmaceuticals Inc (NBY)
0.0842
+0.01
(+9.35%)
USD |
NYAM |
Apr 26, 10:53
NovaBay Pharmaceuticals Net Income (Quarterly): -4.108M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.108M |
| September 30, 2023 | -1.757M |
| June 30, 2023 | -2.036M |
| March 31, 2023 | -1.739M |
| December 31, 2022 | -8.206M |
| September 30, 2022 | -0.136M |
| June 30, 2022 | -2.155M |
| March 31, 2022 | -0.111M |
| December 31, 2021 | -0.158M |
| September 30, 2021 | -2.289M |
| June 30, 2021 | -1.859M |
| March 31, 2021 | -1.518M |
| December 31, 2020 | -1.754M |
| September 30, 2020 | -3.221M |
| June 30, 2020 | -4.482M |
| March 31, 2020 | -1.582M |
| December 31, 2019 | -2.686M |
| September 30, 2019 | -0.282M |
| June 30, 2019 | -2.501M |
| March 31, 2019 | -4.189M |
| December 31, 2018 | -1.268M |
| September 30, 2018 | -1.538M |
| June 30, 2018 | -1.589M |
| March 31, 2018 | -2.15M |
| December 31, 2017 | 0.793M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.447M |
| June 30, 2017 | -1.738M |
| March 31, 2017 | -4.011M |
| December 31, 2016 | -1.648M |
| September 30, 2016 | -3.736M |
| June 30, 2016 | -2.69M |
| March 31, 2016 | -5.077M |
| December 31, 2015 | -4.204M |
| September 30, 2015 | -5.242M |
| June 30, 2015 | -4.887M |
| March 31, 2015 | -4.64M |
| December 31, 2014 | -4.468M |
| September 30, 2014 | -4.219M |
| June 30, 2014 | -2.942M |
| March 31, 2014 | -3.565M |
| December 31, 2013 | -4.137M |
| September 30, 2013 | -3.848M |
| June 30, 2013 | -4.048M |
| March 31, 2013 | -4.009M |
| December 31, 2012 | -2.35M |
| September 30, 2012 | 0.08M |
| June 30, 2012 | -2.226M |
| March 31, 2012 | -2.531M |
| December 31, 2011 | -3.628M |
| September 30, 2011 | 0.106M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.206M
Minimum
Dec 2022
-0.111M
Maximum
Mar 2022
-2.241M
Average
-1.859M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Eyenovia Inc | -7.967M |
| Palatin Technologies Inc | -7.844M |
| iBio Inc | -8.211M |
| Theriva Biologics Inc | -5.485M |
| Oragenics Inc | -12.75M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.727M |
| Total Expenses (Quarterly) | 4.525M |
| EPS Diluted (Quarterly) | -0.8165 |
| Enterprise Value | 2.275M |
| Gross Profit Margin (Quarterly) | 48.70% |
| Profit Margin (Quarterly) | -110.2% |
| Earnings Yield | -3.93K% |
| Normalized Earnings Yield | -3753.60 |